JP2024515086A5 - - Google Patents
Info
- Publication number
- JP2024515086A5 JP2024515086A5 JP2023563986A JP2023563986A JP2024515086A5 JP 2024515086 A5 JP2024515086 A5 JP 2024515086A5 JP 2023563986 A JP2023563986 A JP 2023563986A JP 2023563986 A JP2023563986 A JP 2023563986A JP 2024515086 A5 JP2024515086 A5 JP 2024515086A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarker
- amount
- bilirubin
- subject
- strem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21171497 | 2021-04-30 | ||
| EP21171497.7 | 2021-04-30 | ||
| PCT/EP2022/061543 WO2022229415A2 (en) | 2021-04-30 | 2022-04-29 | Gdf15 marker panels for early detection of sepsis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515086A JP2024515086A (ja) | 2024-04-04 |
| JP2024515086A5 true JP2024515086A5 (https=) | 2025-05-08 |
Family
ID=75746439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563986A Pending JP2024515086A (ja) | 2021-04-30 | 2022-04-29 | 敗血症の早期検出のためのｇｄｆ１５マーカーパネル |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240230673A1 (https=) |
| EP (1) | EP4330684A2 (https=) |
| JP (1) | JP2024515086A (https=) |
| CN (1) | CN117203528A (https=) |
| WO (1) | WO2022229415A2 (https=) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999006445A1 (en) | 1997-07-31 | 1999-02-11 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-15 |
| JP2002543841A (ja) | 1999-05-17 | 2002-12-24 | バイオファーム ゲゼルシャフト ツア バイオテクノロジシェン エントヴィックルング ウント ツム フェルトリーブ フォン ファルマカ エムベーハー | ＴＧＦ−βスーパーファミリーの新規のメンバーであるＧＤＦ―１５の神経保護特性 |
| CA2476597C (en) | 2002-02-28 | 2011-05-17 | Metanomics Gmbh & Co. Kgaa | Mass spectrometry method for analysing mixtures of substances |
| GB0401730D0 (en) * | 2004-01-27 | 2004-03-03 | Bioxell Spa | Diagnosis method |
| WO2005113585A2 (en) | 2004-05-20 | 2005-12-01 | Acceleron Pharma Inc. | Modified tgf-beta superfamily polypeptides |
| US20090197794A1 (en) * | 2005-07-13 | 2009-08-06 | Aird William C | Methods of Diagnosing and Treating an Inflammatory Response |
| CN103123359B (zh) | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
| JP5722587B2 (ja) | 2009-10-13 | 2015-05-20 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス |
| EP2388594A1 (en) * | 2010-05-17 | 2011-11-23 | Roche Diagnostics GmbH | GDF-15 based means and methods for survival and recovery prediction in acute inflammation |
| JP2014505259A (ja) * | 2011-02-03 | 2014-02-27 | アボット・ラボラトリーズ | 慢性心不全における予後診断および診断の方法 |
| EP2490027A1 (en) * | 2011-02-15 | 2012-08-22 | Roche Diagnostics GmbH | Means and methods for diagnosing pregnancy complications based on GDF-15 and PlGF/sFlt1 |
| RU2016112915A (ru) | 2013-09-05 | 2017-10-09 | Эф-Ай-Оу Корпорейшн | Биомаркеры для раннего выявления критической или угрожающей жизни ответной реакции на заболевание и/или ответной реакции на лечение |
-
2022
- 2022-04-29 US US18/557,895 patent/US20240230673A1/en active Pending
- 2022-04-29 JP JP2023563986A patent/JP2024515086A/ja active Pending
- 2022-04-29 CN CN202280030827.XA patent/CN117203528A/zh active Pending
- 2022-04-29 EP EP22726649.1A patent/EP4330684A2/en active Pending
- 2022-04-29 WO PCT/EP2022/061543 patent/WO2022229415A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Diverse cardiopulmonary diseases are associated with distinct xenon magnetic resonance imaging signatures | |
| Kamath et al. | A model to predict survival in patients with end‐stage liver disease | |
| CN101568837A (zh) | 用于预测血管事件和诊断急性冠状动脉综合征的方法 | |
| JP2016520192A (ja) | 腎機能に関連付けられるバイオマーカーおよびそれを使用する方法 | |
| Kawai et al. | Determination of the B-type natriuretic peptide level as a criterion for abnormalities in Japanese individuals in routine clinical practice: the J-ABS Multi-Center Study (Japan Abnormal BNP Standard) | |
| Fung et al. | A biomarker panel for peripheral arterial disease | |
| Ondruschka et al. | Post-mortem in situ stability of serum markers of cerebral damage and acute phase response | |
| Makaryus et al. | Falsely elevated cardiac troponin I levels | |
| Terlecki et al. | Prognostic value of acid-base balance parameters assessed on admission in peripheral venous blood of patients with myocardial infarction treated with percutaneous coronary intervention | |
| Kato et al. | Myocardial Injury by COVID-19 Infection Assessed by Cardiovascular Magnetic Resonance Imaging―A Prospective Multicenter Study― | |
| De Jager et al. | Procalcitonin kinetics in Legionella pneumophila pneumonia | |
| JP2024516678A5 (https=) | ||
| JP2024516680A5 (https=) | ||
| JP2024516677A5 (https=) | ||
| WO2003039349A2 (en) | Method of using physiological markers to estimate cardiovascular risk | |
| RU2020127365A (ru) | Способы, применения и комплекты для диагностики пародонтита | |
| JP2024515086A5 (https=) | ||
| JP2024516001A5 (https=) | ||
| CN115586342B (zh) | 血清可溶性st2在制备预测主动脉夹层患者预后产品中的应用及相关预测装置 | |
| JP2024516679A5 (https=) | ||
| JP2024537774A5 (https=) | ||
| JP2024516681A5 (https=) | ||
| CN111065922A (zh) | 肾上腺髓质素原作为危重病患者的肾脏替代治疗的指标 | |
| WO2024154832A1 (ja) | 全身性強皮症の検出方法 | |
| JP2024516665A5 (https=) |